Found: 4
Select item for more details and to access through your institution.
Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B: 9-23 in autoimmune diabetes.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.926650
- By:
- Publication type:
- Article
An Insulin-Chromogranin A Hybrid Peptide Activates DR11-Restricted T Cells in Human Type 1 Diabetes.
- Published in:
- Diabetes, 2024, v. 73, n. 5, p. 743, doi. 10.2337/db23-0622
- By:
- Publication type:
- Article
Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes.
- Published in:
- Diabetes, 2022, v. 71, n. 12, p. 2793, doi. 10.2337/db22-0303
- By:
- Publication type:
- Article
Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article